TScan Therapeutics TCRX
NASDAQ TCRX
$0.32 +0.00 (+0.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Operating Expenses (2020 - 2026)

Updated

TScan Therapeutics (TCRX) reported Operating Expenses of $31.54 million for Q2 2026, down 24.4% from $41.73 million a year earlier but up 4.7% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Operating Expenses (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, TScan Therapeutics' Operating Expenses came in at $127.65 million, down 15.6% year-over-year; for FY2025, it came in at $146.14 million, up 6.2% from FY2024.

  • Operating Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 39.9% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $137.64 million in FY2024 (+20.2%), $114.51 million in FY2023 (+42.8%), $80.17 million in FY2022 (+36.4%) and $58.78 million in FY2021 (+115.2%).
  • Five-year quarterly Operating Expenses spans a low of $17.06 million in Q4 2021 and a high of $41.73 million in Q2 2025.
  • Year over year, Operating Expenses has now declined in each of the last three quarters, with growth averaging 3.9% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q3 2021 (growth of 144.7%); the low point was Q4 2025 (a decline of 29.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $30.12 million (Q1 2026), $26.43 million (Q4 2025) and $39.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 TScan Therapeutics 40.28 Mn 40.28 Mn - 31.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.54 Mn
Mar 31, 2026 30.12 Mn
Dec 31, 2025 26.43 Mn
Sep 30, 2025 39.56 Mn
Jun 30, 2025 41.73 Mn
Mar 31, 2025 38.42 Mn
Dec 31, 2024 37.38 Mn
Sep 30, 2024 33.67 Mn
Jun 30, 2024 34.65 Mn
Mar 31, 2024 31.94 Mn
Dec 31, 2023 28.57 Mn
Sep 30, 2023 28.64 Mn
Jun 30, 2023 27.76 Mn
Mar 31, 2023 29.55 Mn
Dec 31, 2022 21.74 Mn
Sep 30, 2022 19.94 Mn
Jun 30, 2022 19.30 Mn
Mar 31, 2022 19.18 Mn
Dec 31, 2021 17.06 Mn
Sep 30, 2021 18.25 Mn
API Access

TScan Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=TCRX&period=max&api_key=YOUR_API_KEY